Document Detail

Screening for lung cancer: who should be screened?
MedLine Citation:
PMID:  23194043     Owner:  NLM     Status:  In-Data-Review    
Lung cancer is the most common cause of death from cancer in the United States. Previous studies of screening with chest radiographs and sputum cytology have not been shown to decrease lung cancer mortality. For the first time, a randomized screening trial with low-dose computed tomography scans has demonstrated a 20% lung cancer mortality reduction compared with screenings with a chest x-ray. Investigation is underway on many breath, sputum, and blood biomarkers to determine markers of high risk. The hope is that some (or one) of them will add to the early detection of lung cancer observed with low-dose computed tomography.
James Jett
Related Documents :
15881303 - Oral cancer at a tasmanian tertiary referral clinic, the royal hobart hospital 1996-2002.
19075323 - Application of a diagnostic-therapeutic procedure using implant-supported dental prosth...
537623 - An epidemiologic approach to host factors in the etiology of cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of pathology & laboratory medicine     Volume:  136     ISSN:  1543-2165     ISO Abbreviation:  Arch. Pathol. Lab. Med.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7607091     Medline TA:  Arch Pathol Lab Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1511-4     Citation Subset:  AIM; IM    
From the Department of Medicine, National Jewish Health, Denver, Colorado.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential Diagnosis of Lung Carcinoma With Coherent Anti-Stokes Raman Scattering Imaging.
Next Document:  Root cause analysis of problems in the frozen section diagnosis of in situ, minimally invasive, and ...